Lesser Pork rejections

Higher income for farmer

Description:

Cysvax is a biotechnologically derived immunological veterinary vaccine. The vaccine antigen is the Oncosphere protein encoded by a specific gene (TSOL 18 gene) of Taenia Solium. This antigen is produced by Pichia Pastoris expression system and formulated with an oil adjuvant and recognized to be highly immunogenic.

Composition: Each dose 1 ml contains Taenia Solium oncosphere antigen (TSOL 18) greater or equal to 150 micro grams, Thiomersal (as preservative) ≥ 0.02 % w/v. Mineral oil (as adjuvant) and phosphate buffer diluent q.s.

Potency: Greater or equal to 500 Anti TSOL 18 IgG titre in 5 animals out of 6 by Elisa.

Indications: Cysvax vaccine is indicated for active immunization of pigs against porcine cysticercosis

Target species: Pigs

Dosage and administration: Pigs: 1 ml by deep Intramuscular injection behind the ear area. A sterile needle and syringe should be used for each vaccination.

Cysvax is best used in combination with Oxfenvet (oxfendazole). Animals given Oxfenvet at the time of their second vaccination with Cysvax will have any pre-existing viable infection eliminated by Oxfenvet while Cysvax will prevent the animals from suffering any new infection.

Know more

Vaccination Regimen: Primary vaccination: Pigs approximately 2 months of age and above Booster dose: 3-4 weeks after primary vaccination Re-vaccination: 6 Months.

Immunity: Develops by 2 weeks post booster dose

Contraindications: Do not vaccinate unhealthy animals i.e. animals suffering from diseases, malnutrition, allergic conditions and extreme stress etc.

Precautions: In rare cases, hypersensitivity may occur, immediate treatment with adrenaline & antihistaminic is advocated.

Injection of mineral oil into humans can produce serious localized reactions and special care should be taken to avoid accidental inoculation. If it happens, consult a medical physician immediately.

Generally, corticosteroid therapy should be avoided 1-2 weeks before and after the vaccination for developing good immune response.

Side Effects: Generally, no significant side effects are noticed, however in some animals temporary pyrexia, lethargy for 1-2 days and local injection site reactions for up to 7 days may be observed after vaccination.

Effects with other vaccines: No information is available on the compatibility of this vaccine with any other vaccines. Therefore, the safety and efficacy of this product when used with other vaccines has not been demonstrated.

Withdrawal Period: Zero days.

Overdose: With administration of a 5-fold overdose of vaccine, no adverse reactions were observed under farm conditions other than those described under side effects.

Storage & Transport: The vaccine should be stored and transported between 2°C and8°C

DO NOT FREEZE. SHAKE WELL BEFORE USE. KEEP OUT OF REACH OF CHILDREN.

Shelf Life: 24 months from the date of manufacture when stored at recommended storage conditions.

Disposal of Used Containers: The empty containers of the vaccine, used syringes and needles should be disposed of properly and carefully according to local regulatory requirements.

Presentation: Cysvax is available as 1mL,5mL,10mL & 20mL vial

An initiative by :

Disclaimer: The data contained in this website is intended for general reference only and is meant for viewers in India only. It may refer to pharmaceutical products, diagnostic techniques, therapeutics or indications not yet registered or approved in a given country and it should be noted that, over time, currency and completeness of the data may change. For updated information, please contact the Company. This data should not be used to diagnose, treat, cure or prevent any disease without the professional advice of a Registered Medical Practitioner, and does not replace medical advice or a thorough medical examination. Registered Medical Practitioners should use their independent professional judgement in checking the symptoms, diagnosing & suggesting the appropriate line of treatment for patients. Indian Immunologicals Limited (IIL) is not in any way influencing, propagating or inducing anyone to buy or use IIL products. IIL accepts no liability for any loss, damage or compensation claims in connection with any act or omission by anyone based on information contained in or derived through use of this website. Duplication of or copying any data requires prior permission of the copyright holder. For adverse event reporting with respect to products of IIL, kindly contact our local Drug Safety Unit at info@indimmune.com.